nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrazinamide—CYP3A4—Rosuvastatin—atherosclerosis	0.0952	0.211	CbGbCtD
Pyrazinamide—CYP3A4—Ezetimibe—atherosclerosis	0.0952	0.211	CbGbCtD
Pyrazinamide—CYP3A4—Simvastatin—atherosclerosis	0.0885	0.196	CbGbCtD
Pyrazinamide—CYP3A4—Pravastatin—atherosclerosis	0.0866	0.192	CbGbCtD
Pyrazinamide—CYP3A4—Lovastatin—atherosclerosis	0.0866	0.192	CbGbCtD
Pyrazinamide—Peptic ulcer—Niacin—atherosclerosis	0.00951	0.0281	CcSEcCtD
Pyrazinamide—Hepatomegaly—Niacin—atherosclerosis	0.00898	0.0265	CcSEcCtD
Pyrazinamide—Hepatotoxicity—Niacin—atherosclerosis	0.00823	0.0243	CcSEcCtD
Pyrazinamide—Hyperuricaemia—Niacin—atherosclerosis	0.00685	0.0202	CcSEcCtD
Pyrazinamide—Gout—Niacin—atherosclerosis	0.00681	0.0201	CcSEcCtD
Pyrazinamide—Blood uric acid increased—Niacin—atherosclerosis	0.00648	0.0191	CcSEcCtD
Pyrazinamide—Photosensitivity—Lovastatin—atherosclerosis	0.00612	0.0181	CcSEcCtD
Pyrazinamide—Photosensitivity—Ezetimibe—atherosclerosis	0.006	0.0177	CcSEcCtD
Pyrazinamide—Rash maculo-papular—Niacin—atherosclerosis	0.00578	0.0171	CcSEcCtD
Pyrazinamide—Photosensitivity—Simvastatin—atherosclerosis	0.00572	0.0169	CcSEcCtD
Pyrazinamide—Photosensitivity—Pravastatin—atherosclerosis	0.00518	0.0153	CcSEcCtD
Pyrazinamide—Hepatitis—Rosuvastatin—atherosclerosis	0.00439	0.013	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Lovastatin—atherosclerosis	0.00424	0.0125	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.00416	0.0123	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Simvastatin—atherosclerosis	0.00397	0.0117	CcSEcCtD
Pyrazinamide—Hepatitis—Lovastatin—atherosclerosis	0.00372	0.011	CcSEcCtD
Pyrazinamide—Dysuria—Pravastatin—atherosclerosis	0.00367	0.0108	CcSEcCtD
Pyrazinamide—Hepatitis—Ezetimibe—atherosclerosis	0.00365	0.0108	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Pravastatin—atherosclerosis	0.00359	0.0106	CcSEcCtD
Pyrazinamide—Hepatitis—Simvastatin—atherosclerosis	0.00348	0.0103	CcSEcCtD
Pyrazinamide—Arthralgia—Rosuvastatin—atherosclerosis	0.00325	0.0096	CcSEcCtD
Pyrazinamide—Myalgia—Rosuvastatin—atherosclerosis	0.00325	0.0096	CcSEcCtD
Pyrazinamide—Hepatitis—Niacin—atherosclerosis	0.00319	0.00943	CcSEcCtD
Pyrazinamide—Hepatitis—Pravastatin—atherosclerosis	0.00314	0.00929	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00305	0.00901	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Lovastatin—atherosclerosis	0.003	0.00887	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00295	0.0087	CcSEcCtD
Pyrazinamide—Malaise—Lovastatin—atherosclerosis	0.00292	0.00862	CcSEcCtD
Pyrazinamide—Malaise—Ezetimibe—atherosclerosis	0.00286	0.00846	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00284	0.00839	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Simvastatin—atherosclerosis	0.00281	0.0083	CcSEcCtD
Pyrazinamide—Myalgia—Lovastatin—atherosclerosis	0.00276	0.00814	CcSEcCtD
Pyrazinamide—Arthralgia—Lovastatin—atherosclerosis	0.00276	0.00814	CcSEcCtD
Pyrazinamide—Dyspepsia—Rosuvastatin—atherosclerosis	0.00274	0.0081	CcSEcCtD
Pyrazinamide—Malaise—Simvastatin—atherosclerosis	0.00273	0.00806	CcSEcCtD
Pyrazinamide—Discomfort—Lovastatin—atherosclerosis	0.00272	0.00804	CcSEcCtD
Pyrazinamide—Arthralgia—Ezetimibe—atherosclerosis	0.0027	0.00798	CcSEcCtD
Pyrazinamide—Myalgia—Ezetimibe—atherosclerosis	0.0027	0.00798	CcSEcCtD
Pyrazinamide—Discomfort—Ezetimibe—atherosclerosis	0.00267	0.00789	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Lovastatin—atherosclerosis	0.00259	0.00764	CcSEcCtD
Pyrazinamide—Arthralgia—Simvastatin—atherosclerosis	0.00258	0.00761	CcSEcCtD
Pyrazinamide—Myalgia—Simvastatin—atherosclerosis	0.00258	0.00761	CcSEcCtD
Pyrazinamide—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00257	0.00759	CcSEcCtD
Pyrazinamide—Discomfort—Simvastatin—atherosclerosis	0.00255	0.00752	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Pravastatin—atherosclerosis	0.00254	0.0075	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00254	0.00749	CcSEcCtD
Pyrazinamide—Anorexia—Lovastatin—atherosclerosis	0.00252	0.00744	CcSEcCtD
Pyrazinamide—Urticaria—Rosuvastatin—atherosclerosis	0.00248	0.00731	CcSEcCtD
Pyrazinamide—Malaise—Pravastatin—atherosclerosis	0.00247	0.00729	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Simvastatin—atherosclerosis	0.00242	0.00715	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00241	0.00711	CcSEcCtD
Pyrazinamide—Myalgia—Niacin—atherosclerosis	0.00237	0.00699	CcSEcCtD
Pyrazinamide—Arthralgia—Niacin—atherosclerosis	0.00237	0.00699	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00236	0.00697	CcSEcCtD
Pyrazinamide—Anorexia—Simvastatin—atherosclerosis	0.00236	0.00696	CcSEcCtD
Pyrazinamide—Arthralgia—Pravastatin—atherosclerosis	0.00233	0.00688	CcSEcCtD
Pyrazinamide—Myalgia—Pravastatin—atherosclerosis	0.00233	0.00688	CcSEcCtD
Pyrazinamide—Dyspepsia—Lovastatin—atherosclerosis	0.00233	0.00687	CcSEcCtD
Pyrazinamide—Discomfort—Pravastatin—atherosclerosis	0.0023	0.0068	CcSEcCtD
Pyrazinamide—Hypersensitivity—Rosuvastatin—atherosclerosis	0.0023	0.00678	CcSEcCtD
Pyrazinamide—Decreased appetite—Lovastatin—atherosclerosis	0.0023	0.00678	CcSEcCtD
Pyrazinamide—Dyspepsia—Ezetimibe—atherosclerosis	0.00228	0.00674	CcSEcCtD
Pyrazinamide—Decreased appetite—Ezetimibe—atherosclerosis	0.00225	0.00665	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00225	0.00665	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00224	0.00661	CcSEcCtD
Pyrazinamide—Pruritus—Rosuvastatin—atherosclerosis	0.00221	0.00651	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Pravastatin—atherosclerosis	0.00219	0.00646	CcSEcCtD
Pyrazinamide—Feeling abnormal—Lovastatin—atherosclerosis	0.00218	0.00643	CcSEcCtD
Pyrazinamide—Dyspepsia—Simvastatin—atherosclerosis	0.00217	0.00642	CcSEcCtD
Pyrazinamide—Anorexia—Niacin—atherosclerosis	0.00216	0.00639	CcSEcCtD
Pyrazinamide—Decreased appetite—Simvastatin—atherosclerosis	0.00215	0.00634	CcSEcCtD
Pyrazinamide—Feeling abnormal—Ezetimibe—atherosclerosis	0.00213	0.00631	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00213	0.0063	CcSEcCtD
Pyrazinamide—Anorexia—Pravastatin—atherosclerosis	0.00213	0.00629	CcSEcCtD
Pyrazinamide—Urticaria—Lovastatin—atherosclerosis	0.0021	0.0062	CcSEcCtD
Pyrazinamide—Body temperature increased—Lovastatin—atherosclerosis	0.00209	0.00617	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00207	0.00611	CcSEcCtD
Pyrazinamide—Urticaria—Ezetimibe—atherosclerosis	0.00206	0.00608	CcSEcCtD
Pyrazinamide—Body temperature increased—Ezetimibe—atherosclerosis	0.00205	0.00605	CcSEcCtD
Pyrazinamide—Feeling abnormal—Simvastatin—atherosclerosis	0.00204	0.00601	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00204	0.00601	CcSEcCtD
Pyrazinamide—Dyspepsia—Niacin—atherosclerosis	0.002	0.0059	CcSEcCtD
Pyrazinamide—Decreased appetite—Niacin—atherosclerosis	0.00197	0.00583	CcSEcCtD
Pyrazinamide—Dyspepsia—Pravastatin—atherosclerosis	0.00197	0.00581	CcSEcCtD
Pyrazinamide—Rash—Rosuvastatin—atherosclerosis	0.00197	0.0058	CcSEcCtD
Pyrazinamide—Dermatitis—Rosuvastatin—atherosclerosis	0.00196	0.0058	CcSEcCtD
Pyrazinamide—Urticaria—Simvastatin—atherosclerosis	0.00196	0.0058	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Niacin—atherosclerosis	0.00196	0.00579	CcSEcCtD
Pyrazinamide—Body temperature increased—Simvastatin—atherosclerosis	0.00195	0.00577	CcSEcCtD
Pyrazinamide—Hypersensitivity—Lovastatin—atherosclerosis	0.00195	0.00575	CcSEcCtD
Pyrazinamide—Decreased appetite—Pravastatin—atherosclerosis	0.00194	0.00574	CcSEcCtD
Pyrazinamide—Hypersensitivity—Ezetimibe—atherosclerosis	0.00191	0.00564	CcSEcCtD
Pyrazinamide—Pruritus—Lovastatin—atherosclerosis	0.00187	0.00552	CcSEcCtD
Pyrazinamide—Nausea—Rosuvastatin—atherosclerosis	0.00185	0.00547	CcSEcCtD
Pyrazinamide—Feeling abnormal—Pravastatin—atherosclerosis	0.00184	0.00544	CcSEcCtD
Pyrazinamide—Pruritus—Ezetimibe—atherosclerosis	0.00183	0.00541	CcSEcCtD
Pyrazinamide—Hypersensitivity—Simvastatin—atherosclerosis	0.00182	0.00538	CcSEcCtD
Pyrazinamide—Urticaria—Niacin—atherosclerosis	0.0018	0.00532	CcSEcCtD
Pyrazinamide—Body temperature increased—Niacin—atherosclerosis	0.00179	0.0053	CcSEcCtD
Pyrazinamide—Urticaria—Pravastatin—atherosclerosis	0.00177	0.00524	CcSEcCtD
Pyrazinamide—Body temperature increased—Pravastatin—atherosclerosis	0.00177	0.00522	CcSEcCtD
Pyrazinamide—Pruritus—Simvastatin—atherosclerosis	0.00175	0.00516	CcSEcCtD
Pyrazinamide—Vomiting—Lovastatin—atherosclerosis	0.00168	0.00496	CcSEcCtD
Pyrazinamide—Hypersensitivity—Niacin—atherosclerosis	0.00167	0.00494	CcSEcCtD
Pyrazinamide—Rash—Lovastatin—atherosclerosis	0.00167	0.00492	CcSEcCtD
Pyrazinamide—Dermatitis—Lovastatin—atherosclerosis	0.00166	0.00491	CcSEcCtD
Pyrazinamide—Vomiting—Ezetimibe—atherosclerosis	0.00165	0.00487	CcSEcCtD
Pyrazinamide—Hypersensitivity—Pravastatin—atherosclerosis	0.00165	0.00486	CcSEcCtD
Pyrazinamide—Rash—Ezetimibe—atherosclerosis	0.00163	0.00483	CcSEcCtD
Pyrazinamide—Dermatitis—Ezetimibe—atherosclerosis	0.00163	0.00482	CcSEcCtD
Pyrazinamide—Pruritus—Niacin—atherosclerosis	0.00161	0.00474	CcSEcCtD
Pyrazinamide—Pruritus—Pravastatin—atherosclerosis	0.00158	0.00467	CcSEcCtD
Pyrazinamide—Vomiting—Simvastatin—atherosclerosis	0.00157	0.00464	CcSEcCtD
Pyrazinamide—Nausea—Lovastatin—atherosclerosis	0.00157	0.00463	CcSEcCtD
Pyrazinamide—Rash—Simvastatin—atherosclerosis	0.00156	0.0046	CcSEcCtD
Pyrazinamide—Dermatitis—Simvastatin—atherosclerosis	0.00156	0.0046	CcSEcCtD
Pyrazinamide—Nausea—Ezetimibe—atherosclerosis	0.00154	0.00455	CcSEcCtD
Pyrazinamide—Nausea—Simvastatin—atherosclerosis	0.00147	0.00433	CcSEcCtD
Pyrazinamide—Vomiting—Niacin—atherosclerosis	0.00144	0.00426	CcSEcCtD
Pyrazinamide—Rash—Niacin—atherosclerosis	0.00143	0.00423	CcSEcCtD
Pyrazinamide—Dermatitis—Niacin—atherosclerosis	0.00143	0.00422	CcSEcCtD
Pyrazinamide—Vomiting—Pravastatin—atherosclerosis	0.00142	0.0042	CcSEcCtD
Pyrazinamide—Rash—Pravastatin—atherosclerosis	0.00141	0.00416	CcSEcCtD
Pyrazinamide—Dermatitis—Pravastatin—atherosclerosis	0.00141	0.00416	CcSEcCtD
Pyrazinamide—Nausea—Niacin—atherosclerosis	0.00135	0.00398	CcSEcCtD
Pyrazinamide—Nausea—Pravastatin—atherosclerosis	0.00133	0.00392	CcSEcCtD
Pyrazinamide—AOX1—Metabolism—APOA2—atherosclerosis	0.00031	0.00148	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ALOX15—atherosclerosis	0.00031	0.00148	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ALOX5AP—atherosclerosis	0.00031	0.00148	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	0.000308	0.00147	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ABCG5—atherosclerosis	0.000306	0.00146	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CYP27A1—atherosclerosis	0.000304	0.00145	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CST3—atherosclerosis	0.000298	0.00142	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—LPA—atherosclerosis	0.000295	0.00141	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	0.000288	0.00138	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PLA2G2A—atherosclerosis	0.000288	0.00137	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ALOX5AP—atherosclerosis	0.000288	0.00137	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ALOX15—atherosclerosis	0.000288	0.00137	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—APOA2—atherosclerosis	0.000288	0.00137	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—BGN—atherosclerosis	0.000286	0.00137	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase II conjugation—GSTM1—atherosclerosis	0.000285	0.00136	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ABCG5—atherosclerosis	0.000284	0.00136	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	0.000284	0.00136	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—APOA5—atherosclerosis	0.000283	0.00135	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NAMPT—atherosclerosis	0.000282	0.00135	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atherosclerosis	0.000282	0.00135	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—APOC3—atherosclerosis	0.000279	0.00133	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—LDLR—atherosclerosis	0.000277	0.00132	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—LPA—atherosclerosis	0.000275	0.00131	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PLA2G1B—atherosclerosis	0.000273	0.0013	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—atherosclerosis	0.00027	0.00129	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—HSPA1B—atherosclerosis	0.000267	0.00128	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—BGN—atherosclerosis	0.000266	0.00127	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.000266	0.00127	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ALOX5—atherosclerosis	0.000263	0.00126	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—APOA5—atherosclerosis	0.000263	0.00126	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NCF1—atherosclerosis	0.000259	0.00124	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PLA2G1B—atherosclerosis	0.000254	0.00121	CbGpPWpGaD
Pyrazinamide—CYP1A2—Arachidonic acid metabolism—PTGS2—atherosclerosis	0.000253	0.00121	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atherosclerosis	0.000251	0.0012	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.00025	0.00119	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ALOX5—atherosclerosis	0.000245	0.00117	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CYBA—atherosclerosis	0.000243	0.00116	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PARP1—atherosclerosis	0.000238	0.00114	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—NAMPT—atherosclerosis	0.000236	0.00113	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—LIPC—atherosclerosis	0.000235	0.00112	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—atherosclerosis	0.000234	0.00112	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—APOC3—atherosclerosis	0.000233	0.00111	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—LDLR—atherosclerosis	0.000232	0.00111	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CETP—atherosclerosis	0.000226	0.00108	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—NAMPT—atherosclerosis	0.00022	0.00105	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—LIPC—atherosclerosis	0.000218	0.00104	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—SCARB1—atherosclerosis	0.000217	0.00104	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—APOC3—atherosclerosis	0.000217	0.00104	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.000217	0.00103	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.000217	0.00103	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—LDLR—atherosclerosis	0.000216	0.00103	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—atherosclerosis	0.000213	0.00102	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CETP—atherosclerosis	0.000211	0.00101	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—HMGCR—atherosclerosis	0.000205	0.000978	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—SCARB1—atherosclerosis	0.000202	0.000963	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—atherosclerosis	0.000195	0.000933	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—HMGCR—atherosclerosis	0.00019	0.000909	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ABCA1—atherosclerosis	0.000183	0.000872	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atherosclerosis	0.000182	0.000871	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atherosclerosis	0.000182	0.000871	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—APOB—atherosclerosis	0.000179	0.000855	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000171	0.000817	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—LPL—atherosclerosis	0.000171	0.000817	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ABCA1—atherosclerosis	0.00017	0.00081	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—GSTM1—atherosclerosis	0.000167	0.000797	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PRKCG—atherosclerosis	0.000166	0.000794	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—GSTM1—atherosclerosis	0.000165	0.000786	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000161	0.000769	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000161	0.000769	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.000158	0.000754	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—HMOX1—atherosclerosis	0.000157	0.000748	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.000155	0.000741	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MTHFR—atherosclerosis	0.000154	0.000735	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—APOB—atherosclerosis	0.00015	0.000716	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PDGFB—atherosclerosis	0.00015	0.000716	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GSTM1—atherosclerosis	0.000146	0.000697	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—HMOX1—atherosclerosis	0.000146	0.000695	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000143	0.000685	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—APOE—atherosclerosis	0.000143	0.000685	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—LPL—atherosclerosis	0.000143	0.000684	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CAV1—atherosclerosis	0.000142	0.000678	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—APOA1—atherosclerosis	0.000142	0.000677	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GPX1—atherosclerosis	0.00014	0.000667	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—APOB—atherosclerosis	0.000139	0.000666	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CD36—atherosclerosis	0.000136	0.00065	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000136	0.000649	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000136	0.000649	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000136	0.000649	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000136	0.000649	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GSTM1—atherosclerosis	0.000136	0.000648	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000134	0.000641	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NOS2—atherosclerosis	0.000134	0.000638	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—LPL—atherosclerosis	0.000133	0.000636	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GPX1—atherosclerosis	0.00013	0.00062	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.00013	0.000619	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—MTHFR—atherosclerosis	0.000129	0.000616	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	0.000129	0.000615	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	0.000127	0.000606	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CD36—atherosclerosis	0.000127	0.000604	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PPARA—atherosclerosis	0.000127	0.000604	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.000124	0.000594	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—AGT—atherosclerosis	0.000123	0.000585	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—INS—atherosclerosis	0.000122	0.000585	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—APOE—atherosclerosis	0.00012	0.000573	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—MTHFR—atherosclerosis	0.00012	0.000573	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.00012	0.000572	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CAV1—atherosclerosis	0.000119	0.000568	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—APOA1—atherosclerosis	0.000119	0.000567	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—LDLRAP1—atherosclerosis	0.000118	0.000565	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PPARA—atherosclerosis	0.000118	0.000562	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.000116	0.000552	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—AGT—atherosclerosis	0.000114	0.000544	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—SERPINE1—atherosclerosis	0.000113	0.000537	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—APOE—atherosclerosis	0.000112	0.000533	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PLTP—atherosclerosis	0.000111	0.000531	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CAV1—atherosclerosis	0.000111	0.000528	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—APOA1—atherosclerosis	0.00011	0.000527	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PIK3CG—atherosclerosis	0.000108	0.000517	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NOS3—atherosclerosis	0.000107	0.000513	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PPARG—atherosclerosis	0.000105	0.000499	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.000103	0.000492	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—INS—atherosclerosis	0.000103	0.00049	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000102	0.000489	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.000102	0.000486	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PIK3CG—atherosclerosis	0.000101	0.000481	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	9.94e-05	0.000475	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PTGS2—atherosclerosis	9.82e-05	0.000469	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PPARG—atherosclerosis	9.72e-05	0.000464	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—LTA4H—atherosclerosis	9.64e-05	0.000461	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ABCG8—atherosclerosis	9.64e-05	0.000461	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—INS—atherosclerosis	9.54e-05	0.000455	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	9.52e-05	0.000455	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ALB—atherosclerosis	9.4e-05	0.000449	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	9.13e-05	0.000436	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—NOS3—atherosclerosis	9e-05	0.00043	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	8.99e-05	0.000429	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ALB—atherosclerosis	8.74e-05	0.000417	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PLTP—atherosclerosis	8.58e-05	0.00041	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—NOS3—atherosclerosis	8.36e-05	0.000399	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PTGS2—atherosclerosis	8.23e-05	0.000393	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	8.01e-05	0.000383	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—STAT3—atherosclerosis	7.66e-05	0.000366	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PTGS2—atherosclerosis	7.65e-05	0.000365	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ABCG1—atherosclerosis	7.62e-05	0.000364	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—LTA4H—atherosclerosis	7.44e-05	0.000355	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ABCG8—atherosclerosis	7.44e-05	0.000355	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MAPK3—atherosclerosis	7.32e-05	0.00035	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—FABP4—atherosclerosis	7.17e-05	0.000342	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—LCAT—atherosclerosis	7.17e-05	0.000342	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—TGFB1—atherosclerosis	7.1e-05	0.000339	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—APOA4—atherosclerosis	7.04e-05	0.000336	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP7A1—atherosclerosis	6.91e-05	0.00033	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	6.59e-05	0.000315	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP27A1—atherosclerosis	6.39e-05	0.000305	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	6.29e-05	0.0003	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	6.14e-05	0.000293	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	6.06e-05	0.000289	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALOX15—atherosclerosis	6.06e-05	0.000289	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	6.06e-05	0.000289	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—APOA2—atherosclerosis	6.06e-05	0.000289	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ABCG5—atherosclerosis	5.98e-05	0.000286	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	5.98e-05	0.000285	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ABCG1—atherosclerosis	5.88e-05	0.000281	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—LPA—atherosclerosis	5.78e-05	0.000276	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—BGN—atherosclerosis	5.6e-05	0.000267	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	5.56e-05	0.000265	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—APOA5—atherosclerosis	5.54e-05	0.000264	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—FABP4—atherosclerosis	5.53e-05	0.000264	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—LCAT—atherosclerosis	5.53e-05	0.000264	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—APOA4—atherosclerosis	5.43e-05	0.000259	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	5.38e-05	0.000257	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—IL6—atherosclerosis	5.35e-05	0.000256	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP7A1—atherosclerosis	5.33e-05	0.000255	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	5.33e-05	0.000255	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	5.27e-05	0.000252	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	5.22e-05	0.000249	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	5.21e-05	0.000249	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALOX5—atherosclerosis	5.15e-05	0.000246	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—AKT1—atherosclerosis	4.94e-05	0.000236	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP27A1—atherosclerosis	4.93e-05	0.000235	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.76e-05	0.000227	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—APOA2—atherosclerosis	4.67e-05	0.000223	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	4.67e-05	0.000223	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	4.67e-05	0.000223	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALOX15—atherosclerosis	4.67e-05	0.000223	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NAMPT—atherosclerosis	4.62e-05	0.000221	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ABCG5—atherosclerosis	4.62e-05	0.00022	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	4.59e-05	0.000219	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—LIPC—atherosclerosis	4.59e-05	0.000219	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—APOC3—atherosclerosis	4.56e-05	0.000218	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—LDLR—atherosclerosis	4.53e-05	0.000216	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—LPA—atherosclerosis	4.46e-05	0.000213	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CETP—atherosclerosis	4.43e-05	0.000211	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—BGN—atherosclerosis	4.32e-05	0.000206	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—APOA5—atherosclerosis	4.27e-05	0.000204	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SCARB1—atherosclerosis	4.24e-05	0.000202	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—AKT1—atherosclerosis	4.13e-05	0.000197	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.13e-05	0.000197	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	4.12e-05	0.000196	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HMGCR—atherosclerosis	4e-05	0.000191	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALOX5—atherosclerosis	3.97e-05	0.00019	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—AKT1—atherosclerosis	3.84e-05	0.000184	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.61e-05	0.000172	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ABCA1—atherosclerosis	3.57e-05	0.00017	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NAMPT—atherosclerosis	3.56e-05	0.00017	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—LIPC—atherosclerosis	3.54e-05	0.000169	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—APOC3—atherosclerosis	3.52e-05	0.000168	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—LDLR—atherosclerosis	3.5e-05	0.000167	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CETP—atherosclerosis	3.42e-05	0.000163	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SCARB1—atherosclerosis	3.27e-05	0.000156	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HMGCR—atherosclerosis	3.09e-05	0.000148	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HMOX1—atherosclerosis	3.06e-05	0.000146	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—APOB—atherosclerosis	2.93e-05	0.00014	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTM1—atherosclerosis	2.85e-05	0.000136	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—LPL—atherosclerosis	2.8e-05	0.000134	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.75e-05	0.000132	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GPX1—atherosclerosis	2.73e-05	0.00013	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CD36—atherosclerosis	2.66e-05	0.000127	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—MTHFR—atherosclerosis	2.52e-05	0.00012	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PPARA—atherosclerosis	2.47e-05	0.000118	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—AGT—atherosclerosis	2.4e-05	0.000114	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.36e-05	0.000113	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—APOE—atherosclerosis	2.35e-05	0.000112	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CAV1—atherosclerosis	2.33e-05	0.000111	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—APOA1—atherosclerosis	2.32e-05	0.000111	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—APOB—atherosclerosis	2.26e-05	0.000108	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.2e-05	0.000105	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—LPL—atherosclerosis	2.16e-05	0.000103	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PIK3CG—atherosclerosis	2.12e-05	0.000101	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GPX1—atherosclerosis	2.11e-05	0.000101	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CD36—atherosclerosis	2.05e-05	9.81e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PPARG—atherosclerosis	2.04e-05	9.76e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—INS—atherosclerosis	2.01e-05	9.58e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.95e-05	9.29e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PPARA—atherosclerosis	1.91e-05	9.12e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—AGT—atherosclerosis	1.85e-05	8.83e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALB—atherosclerosis	1.84e-05	8.78e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—APOE—atherosclerosis	1.81e-05	8.65e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CAV1—atherosclerosis	1.8e-05	8.57e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—APOA1—atherosclerosis	1.79e-05	8.55e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NOS3—atherosclerosis	1.76e-05	8.4e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.64e-05	7.81e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PTGS2—atherosclerosis	1.61e-05	7.68e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PPARG—atherosclerosis	1.58e-05	7.54e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—INS—atherosclerosis	1.55e-05	7.39e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALB—atherosclerosis	1.42e-05	6.78e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NOS3—atherosclerosis	1.36e-05	6.48e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.24e-05	5.93e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—AKT1—atherosclerosis	8.09e-06	3.86e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—AKT1—atherosclerosis	6.24e-06	2.98e-05	CbGpPWpGaD
